Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

Published:2016-06-24 Issue:6 Volume:11 Page:e0158242
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Faridi Rehan Mujeeb,Kemp Taylor J.,Dharmani-Khan Poonam,Lewis Victor,Tripathi Gaurav^ORCID,Rajalingam Raja,Daly Andrew^ORCID,Berka Noureddine,Storek Jan,Masood Khan Faisal

Funder

Alberta Innovates - Health Solutions

Alberta Children's Hospital Foundation

Calgary Laboratory Services

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation;ED Thomas,2009

2. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation;PL Weiden;N Engl J Med,1981

3. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis;JA Russell;Biol Blood Marrow Transplant,2007